The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats
The effects of brofaromine, a reversible inhibitor of MAO-A, on the extracellular content of serotonin (5-hydroxytryptamine, 5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) have been studied in two regions of the rat brain (midbrain raphe nuclei and frontal cortex). In both areas, locally infused brofaromine induced dose-dependent increases of 5-HT which were more marked in the raphe nuclei. Brofaromine increased extracellular 5-HT more markedly than clorgyline, suggesting that other factors (i.e. inhibition of 5-HT uptake) may be involved in its local effects. Systemic (3 mg/kg, s.c.) brofaromine did not modify extracellular 5-HT in any brain area examined. In contrast, the concurrent administration of brofaromine and deprenyl led to significant changes in the concentration of 5-HT and 5-HIAA in the brain extracellular space. The results are discussed in relation to the role of MAO-A in the control of 5-HT output.
KeywordsFrontal Cortex Raphe Nucleus Serotoninergic Neurone Extracellular Serotonin Extracellular Content
Unable to display preview. Download preview PDF.
- Celada P, Pérez J, Alvarez E, Artigas F (1992) Monoamine oxidase inhibitors phenel-zine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in major depressive patients. Relationship to clinical improvement. J Clin Psychopharmacol 12: 309–315.PubMedCrossRefGoogle Scholar
- Waldmeier PC, Baumann PA, Delini-Stula A, Bernasconi R, Sigg K, Buech O, Feiner AE (1983) Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase. Mod Probi Pharmacopsychiatry 19: 31–52.Google Scholar